Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28724
Title: Selective intra-arterial calcium stimulation test for the localization of insulinomas: an Australian hospital experience.
Authors: Sachithanandan N.;Graf A.;Sarlos S.;Farrell S.G.;MacIsaac R.J.;Inder W.J.
Monash Health Department(s): Endocrinology
Institution: (Graf, MacIsaac, Sachithanandan) Department of Diabetes and Endocrinology, St Vincent's Hospital Melbourne, VIC, Australia (Sarlos) Department of Endocrinology, Monash Health, Clayton, VIC, Australia (Sarlos) Department of Medicine, Monash University, Clayton, VIC, Australia (Farrell) Department of Surgery, St Vincent's Hospital Melbourne, VIC, Australia (MacIsaac, Sachithanandan) Department of Medicine St Vincent's Hospital Melbourne, University of Melbourne, VIC, Australia (Inder) Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, QLD, Australia (Inder) Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia
Issue Date: 12-May-2020
Copyright year: 2020
Publisher: NLM (Medline)
Place of publication: Australia
Publication information: ANZ journal of surgery. 90 (12) (pp E172-E176), 2020. Date of Publication: 01 Dec 2020.
Journal: ANZ Journal of Surgery
Abstract: BACKGROUND: Insulinomas are rare tumours of the pancreas and the most common cause of hypoglycaemia in non-diabetic adults. They can be cured by surgery but require precise localization. The aim of this study was to assess the utility of the selective intra-arterial calcium stimulation test (SIACST) in patients with an insulinoma to correctly localize the tumour. METHOD(S): Medical records of patients with a diagnosis of insulinoma or who underwent an SIACST were retrospectively reviewed. Localization of lesions by SIACST was compared to endoscopic ultrasound and radionuclide imaging studies and verified against findings at surgery. RESULT(S): A total of 24 patients (mean age 58years, 16 females, 20 with insulinoma) underwent SIACST. The SIACST correctly localized the insulinoma in 17 of 20 patients (85%). Localization rate for computed tomography was 55% and 75% for endoscopic ultrasound and glucagon-like peptide-1 receptor scan. CONCLUSION(S): SIACST provided incremental diagnostic information in patients with insulinoma who had equivocal non-invasive imaging preoperatively. This technique remains an essential diagnostic tool when a lesion is not localized by other methods.Copyright © 2020 Royal Australasian College of Surgeons.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/ans.15913
PubMed URL: 32356594 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32356594]
ISSN: 1445-2197 (electronic)
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/28724
Type: Article
Subjects: computer assisted tomography
controlled study
diagnosis
*endocrine surgery
*endoscopic ultrasonography
female
human
*insulinoma
medical record
middle aged
preoperative evaluation
retrospective study
scintiscanning
*calcium
endogenous compound
glucagon like peptide 1 receptor
adult
*provocation test
article
clinical article
computer assisted tomography
endocrine surgery
endoscopic ultrasonography
insulinoma
medical record
preoperative evaluation
scintiscanning
calcium
glucagon like peptide 1 receptor
provocation test
medical record [m]
middle aged [m]
preoperative evaluation [m]
*provocation test [m]
retrospective study [m]
scintiscanning [m]
human [m]
female [m]
*endoscopic ultrasonography [m]
*endocrine surgery [m]
diagnosis [m]
adult [m]
clinical article [m]
article [m]
*insulinoma [m]
controlled study [m]
computer assisted tomography [m]
Type of Clinical Study or Trial: Observational study (cohort, case-control, cross sectional or survey)
Appears in Collections:Articles

Show full item record

Page view(s)

6
checked on Aug 29, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.